Form 4: OraSure Director Lelio Marmora Receives Stock Grant

Director Lelio Marmora was granted 46,106 restricted shares of OraSure Technologies, increasing his total ownership to 148,460 shares.

Summary

• Lelio Marmora, a Director at OraSure Technologies, received a grant of 46,106 restricted shares on June 3, 2026.
• The shares were granted at no cost ($0.00) as part of the company's Stock Award Plan.
• Following this transaction, Marmora directly owns 148,460 shares of common stock.
• The restricted shares are scheduled to vest in full on June 3, 2027, or immediately prior to the 2027 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event that reinforces insider alignment without indicating a change in company fundamentals.

Positives

• Increased insider ownership aligns the director's financial interests with those of the shareholders.
• The grant includes a one-year vesting period, encouraging long-term commitment to the board of directors.

Negatives

• The grant represents potential dilution for existing shareholders, although this is a standard component of director compensation.

Risks

• Vesting is contingent on continued service; if the director voluntarily ceases to serve on the board, the unvested shares will be forfeited.

Future Outlook

The grant ensures the director remains incentivized through the 2027 fiscal year, with vesting tied to the 2027 Annual Meeting of Stockholders.

Management Comments

• Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard practice in the medical diagnostics and biotechnology industry to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant size is consistent with mid-cap biotechnology director compensation packages.
• A one-year cliff vesting schedule is a standard governance practice for annual director equity awards among NASDAQ-listed companies.

Corporate Governance

Related Party Transactions

• The grant of stock to a director is a transaction between the issuer and an insider, typically governed by the company's compensation policies.

Stakeholder Impact

• Shareholders may experience minor dilution from the issuance of 46,106 new shares upon vesting.

Next Steps

• Vesting of shares on June 3, 2027, or the date of the 2027 Annual Meeting.

Key Dates

Recommendation

This filing represents a routine compensation event for a board member and does not provide new information regarding the company's operational performance or financial outlook that would warrant a change in investment rating.

Keywords

OraSure Technologies, OSUR, Insider Trading, Form 4, Stock Grant, Lelio Marmora, Restricted Stock, Director Compensation